NL8900610A - Methode voor het behandelen van osteoporose. - Google Patents

Methode voor het behandelen van osteoporose. Download PDF

Info

Publication number
NL8900610A
NL8900610A NL8900610A NL8900610A NL8900610A NL 8900610 A NL8900610 A NL 8900610A NL 8900610 A NL8900610 A NL 8900610A NL 8900610 A NL8900610 A NL 8900610A NL 8900610 A NL8900610 A NL 8900610A
Authority
NL
Netherlands
Prior art keywords
progestin
use according
administered
bone
estrogen
Prior art date
Application number
NL8900610A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888806028A external-priority patent/GB8806028D0/en
Priority claimed from GB888813740A external-priority patent/GB8813740D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8900610A publication Critical patent/NL8900610A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NL8900610A 1988-03-14 1989-03-14 Methode voor het behandelen van osteoporose. NL8900610A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888806028A GB8806028D0 (en) 1988-03-14 1988-03-14 Improvements in/relating to organic compounds
GB8806028 1988-03-14
GB888813740A GB8813740D0 (en) 1988-06-10 1988-06-10 Improvements in/relating to organic compounds
GB8813740 1988-06-10

Publications (1)

Publication Number Publication Date
NL8900610A true NL8900610A (nl) 1989-10-02

Family

ID=26293634

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8900610A NL8900610A (nl) 1988-03-14 1989-03-14 Methode voor het behandelen van osteoporose.

Country Status (13)

Country Link
EP (1) EP0337938A3 (de)
JP (1) JPH029820A (de)
AU (1) AU3131389A (de)
BE (1) BE1002310A4 (de)
CH (1) CH678814A5 (de)
DE (1) DE3908130A1 (de)
DK (1) DK120389A (de)
FR (1) FR2628321A1 (de)
GB (1) GB2216420B (de)
HU (1) HUT52382A (de)
IT (1) IT1232822B (de)
NL (1) NL8900610A (de)
SE (1) SE8900875L (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8166191A (en) * 1990-08-10 1992-02-13 Ortho Pharmaceutical Corporation Method for treatment of bone wasting diseases
US6037339A (en) 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
DE4405590C1 (de) * 1994-02-22 1995-07-20 Hesch Rolf Dieter Prof Dr Med Mittel zur postmenopausalen Hormonbehandlung
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
EP1673071A1 (de) 2003-09-29 2006-06-28 Novo Nordisk Femcare AG Verbesserte stabilität von progestogen-formulierungen
CN101869080B (zh) * 2010-06-08 2012-10-03 中国水产科学研究院渔业机械仪器研究所 一种网箱污物收集装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB235090A (en) * 1924-06-26 1925-06-11 Hermann Haas Cloth shearing machines
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
ZA87332B (en) * 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag

Also Published As

Publication number Publication date
IT8947740A0 (it) 1989-03-14
SE8900875D0 (sv) 1989-03-13
DK120389A (da) 1989-09-15
GB2216420A (en) 1989-10-11
FR2628321A1 (fr) 1989-09-15
DK120389D0 (da) 1989-03-13
DE3908130A1 (de) 1989-10-05
JPH029820A (ja) 1990-01-12
EP0337938A3 (de) 1990-09-12
CH678814A5 (de) 1991-11-15
GB8905714D0 (en) 1989-04-26
EP0337938A2 (de) 1989-10-18
BE1002310A4 (fr) 1990-11-27
SE8900875L (sv) 1989-12-15
GB2216420B (en) 1991-12-11
IT1232822B (it) 1992-03-05
AU3131389A (en) 1989-09-14
HUT52382A (en) 1990-07-28

Similar Documents

Publication Publication Date Title
Overgaard et al. Effect of salcatonin given intranasally on early postmenopausal bone loss.
Munk-Jensen et al. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study
Overgaard et al. Nasal calcitonin for treatment of established osteoporosis
CHRISTIANSEN et al. 17 β-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women
Aloia et al. Calcitriol in the treatment of postmenopausal osteoporosis
Bagger et al. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study
Nappi et al. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study
EA004573B1 (ru) Способы лечения женщин в постклимактерическом состоянии с применением ультранизких доз эстрогена
McNair et al. Development of bone mineral loss in insulin‐treated diabetes: a 1 1/2 years follow‐up study in sixty patients
Massaro et al. Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study
GOULDING et al. Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving β-estradiol
Rymer et al. Effect of tibolone on postmenopausal bone loss
Greene et al. Benign symmetric lipomatosis (Launois-Bensaude adenolipomatosis) with gout and hyperlipoproteinemia
Philip et al. Decreased axial and peripheral bone density in patients taking long-term warfarin
Hoikka et al. Carbamazepine and bone mineral metabolism
Riis et al. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women
Johansson et al. Reproductive factors as predictors of bone density and fractures in women at the age of 70
Chojnacki et al. The effect of long-term melatonin supplementation on psychosomatic disorders in postmenopausal women
Luotola et al. Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in post-menopausal women
Riis et al. Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy
NL8900610A (nl) Methode voor het behandelen van osteoporose.
Passeri et al. Effect of ipriflavone on bone mass in elderly osteoporotic women
Hassager et al. Collagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones
Hassager et al. Blood pressure during oestrogen/progestogen substitution therapy in healthy post-menopausal women
Marshall et al. THE EFFECT OF lα‐HYDROXYVITAMIN D3 WITH AND WITHOUT OESTROGENS ON CALCIUM BALANCE IN POST‐MENOPAUSAL WOMEN

Legal Events

Date Code Title Description
BV The patent application has lapsed